Phillips-Medisize Appoints Rob Werge as VP/GM Global Commercial Division
Phillips-Medisize Corporation announces the appointment of Rob Werge to the position of VP/GM Global Commercial Division, effective August 1, 2013.
August 1, 2013 (Hudson, WI) — Today, Phillips-Medisize Corporation announced the appointment of Rob Werge to the position of VP/GM Global Commercial Division, effective Augu...
August 1, 2013 (Hudson, WI) — Today, Phillips-Medisize Corporation announced the appointment of Rob Werge to the position of VP/GM Global Commercial Division, effective August 1, 2013.
“Several people have stated that Rob was integral to the growth of Nypro, so we are glad he is joining the Phillips-Medisize team,” commented Matt Jennings, President and CEO.
Rob comes to Phillips-Medisize with 24 years of experience with Nypro where he began his career in operations and pre-production working on automation, tooling and process improvement projects. From there, he became involved in launching custom drug delivery products in the medical products group, followed by a promotion of Global Business Unit Manager for the Consumer/Industrial global market segment. Rob was named VP Sales for the Americas Region, responsible for a team of 28 sales professionals and $500 million of business across four major markets; Healthcare, Consumer/Electronics, Packaging and Automotive. His most recent role was VP Emerging Markets where he was responsible for developing and executing a five-year strategic roadmap for the molding and tooling businesses at Nypro Forbes India. Through the years Rob has cultivated solid relationships with many customers.
Werge adds, "I am excited to join an outstanding team at Phillips-Medisize and look forward to helping them drive growth and continued success in the commercial space."
About Phillips-Medisize Corporation
Phillips-Medisize is a leading global outsource provider of design and manufacturing services to the medical device and diagnostics, drug delivery and commercial markets. The company has annual sales of just under $500 million with 75% of the total revenue coming from drug delivery, medical device and diagnostic products such as: disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components. Phillips-Medisize Corporation features a list of blue chip medical device, pharmaceutical and commercial customers. The company partners with its customers to provide design and development services which accelerate speed to market of innovative products and then works with its customers to deploy advanced automated assembly and quality control technologies which reduce manufacturing cost while improving quality. The company’s core advantage is the knowledge of its people to integrate design, molding, and automation to drive low cost and high quality manufacturing solutions. Phillips-Medisize Corporation is headquartered in Hudson, WI, and employs over 2,100 people in 19 locations throughout the United States, Europe and China. The company also has design centers in Wisconsin, California, and The Netherlands. To learn more about Phillips-Medisize visit the company website at www.phillipsmedisize.com.
For more information contact Phillips-Medisize